Jun 12, 2024
HCL Technologies Share Price Jumps 3% on Major Deal with apoBank; Morgan Stanley Reaffirms ‘Overweight’ Rating
HCL Technologies’ share price increased by 3% following a major deal with apoBank. Morgan Stanley reaffirmed its ‘Overweight’ rating, citing HCL’s strong growth prospects and robust fundamentals, underscoring the deal's potential to enhance HCL’s market position and shareholder value.

